David M. Knott Jr’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-39,036
Closed -$1.57M 98
2024
Q4
$1.57M Hold
39,036
0.57% 25
2024
Q3
$2.47M Sell
39,036
-37,000
-49% -$2.17M 0.87% 25
2024
Q2
$4.03M Sell
76,036
-25,400
-25% -$1.66M 1.61% 14
2024
Q1
$8.32M Sell
101,436
-169,386
-63% -$7.54M 2.94% 7
2023
Q4
$5.04M Buy
270,822
+85,267
+46% +$1.12M 1.93% 11
2023
Q3
$2.05M Buy
185,555
+110,006
+146% +$1.57M 0.78% 24
2023
Q2
$1.23M Sell
75,549
-124,615
-62% -$2.61M 0.49% 37
2023
Q1
$3.33M Sell
200,164
-181,457
-48% -$1.87M 1.31% 16
2022
Q4
$3.59M Buy
381,621
+79,818
+26% +$356K 1.36% 17
2022
Q3
$821K Buy
301,803
+35,000
+13% +$115K 0.35% 51
2022
Q2
$771K Buy
266,803
+38,701
+17% +$95.8K 0.32% 56
2022
Q1
$684K Buy
228,102
+20,000
+10% +$71.7K 0.22% 70
2021
Q4
$957K Buy
+208,102
New +$1.17M 0.33% 53

Other funds holding VKTX